ACLS Provider: Course

Incorrect. The compression-to-ventilation ratio for single-rescuer infant CPR is 30:2, ensuring sufficient oxygenation and circulation.

Incorrect. Asystole is a non-shockable rhythm requiring immediate high-quality CPR and administration of epinephrine.

Incorrect. PEA is treated with CPR and epinephrine, as defibrillation is ineffective for non-shockable rhythms.

Incorrect. Delivering 1 breath every 5-6 seconds prevents hypoventilation or hyperventilation.

Incorrect. Hypovolemia is a reversible cause of cardiac arrest that can be treated with fluid resuscitation to restore circulation.

Incorrect. Pediatric defibrillation starts at 2 J/kg, increasing to 4 J/kg for subsequent shocks if needed.

Incorrect. Atropine is the first-line drug for symptomatic bradycardia, increasing heart rate by blocking vagal stimulation.

Incorrect. Adenosine is used to terminate stable narrow-complex tachycardia by slowing AV node conduction.

Incorrect. The jaw thrust maneuver opens the airway without manipulating the cervical spine, protecting against spinal cord injury.

Incorrect. PETCO2 monitoring provides continuous feedback on the quality of chest compressions and the effectiveness of resuscitation.

Incorrect. CPR should be resumed immediately after defibrillation to maintain perfusion and increase the likelihood of ROSC.

Incorrect. Pausing compressions for more than 10 seconds interrupts perfusion and reduces the chances of ROSC.

Incorrect. Stabilizes the myocardium and suppresses arrhythmias during refractory VF or pulseless VT.

Incorrect. Epinephrine is given first in VF during cardiac arrest, followed by amiodarone as an antiarrhythmic after defibrillation attempts.

Incorrect. Atropine is given at a dose of 0.5 mg every 3-5 minutes during bradycardia, up to a maximum dose of 3 mg.

Incorrect. Chest compressions are performed to dislodge the obstruction and restore effective ventilation in an unresponsive infant.

Incorrect. Epinephrine is given every 3-5 minutes to enhance coronary and cerebral perfusion during cardiac arrest.

Incorrect. Needle decompression relieves pressure caused by tension pneumothorax, improving ventilation and circulation.

Incorrect. ROSC stands for "Return of Spontaneous Circulation," indicating the resumption of a perfusing rhythm.

Incorrect. PETCO2 monitoring helps assess the effectiveness of both ventilation and chest compressions in real-time during CPR.

Incorrect. Magnesium sulfate stabilizes cardiac myocytes and is the drug of choice for treating torsades de pointes.

Incorrect. Atrial fibrillation is cardioverted starting at 120-200 J in synchronized mode to avoid delivering the shock during ventricular repolarization.

Incorrect. The jaw thrust technique opens the airway while minimizing cervical spine movement, reducing the risk of further injury.

Incorrect. Epinephrine at 0.01 mg/kg is administered every 3-5 minutes during pediatric cardiac arrest to improve coronary perfusion.

Incorrect. Adenosine is the first-line drug for stable SVT, while synchronized cardioversion is used for unstable SVT.

Incorrect. Activating EMS ensures help is on the way while you assess and initiate resuscitation.

Incorrect. Defibrillation should be performed immediately after identifying VF, not delayed up to 10 minutes.

Incorrect. PETCO2 readings above 10 mmHg during CPR indicate adequate chest compressions and cardiac output.

Incorrect. A 30:2 ratio ensures adequate oxygenation and circulation when no advanced airway is present.

Incorrect. Biphasic defibrillators deliver effective shocks within the range of 120-200 J, restoring organized electrical activity.

Incorrect. With an advanced airway, compressions continue uninterrupted while ventilation is provided at a rate of 10 breaths per minute.

Incorrect. Adenosine is used for narrow-complex SVT, not wide-complex tachycardia, which is typically treated with amiodarone.

Incorrect. Adenosine is administered at 0.1 mg/kg as a rapid IV push for terminating narrow-complex SVT caused by reentrant pathways.

Incorrect. High-quality CPR is the primary treatment for asystole, along with epinephrine and addressing reversible causes.

Incorrect. PETCO2 >10 mmHg during CPR indicates effective chest compressions generating sufficient circulation.

Incorrect. Magnesium sulfate is administered to stabilize the myocardium and treat torsades de pointes effectively.

Incorrect. The 15:2 ratio improves oxygenation and circulation during high-quality infant CPR performed by two rescuers.

Incorrect. Ventricular fibrillation presents as a disorganized rhythm that requires immediate defibrillation.

Incorrect. Chest compressions for infants should be about 1/3 the depth of the chest, approximately 1.5 inches (4 cm).

Incorrect. Pediatric defibrillation starts at 2 J/kg to safely deliver an effective shock without causing harm.

Incorrect. Requires immediate defibrillation to restore organized cardiac activity.

Incorrect. Pediatric defibrillation starts with 2 J/kg, increasing to 4 J/kg for subsequent shocks if needed.

Incorrect. Naloxone is used to reverse opioid overdose, restoring respiratory effort in patients with respiratory depression.

Incorrect. Magnesium sulfate stabilizes the cardiac membrane and is the drug of choice for treating torsades de pointes.

Incorrect. A 30:2 ratio ensures sufficient oxygenation and circulation in adults during CPR without an advanced airway.

Incorrect. Synchronized cardioversion is used to restore a normal rhythm in unstable atrial fibrillation.

Incorrect. Compressions at 1/3 the depth of the chest ensure adequate perfusion while minimizing injury to internal organs.

Incorrect. Asystole is a non-shockable rhythm requiring immediate CPR and epinephrine administration.

Incorrect. Magnesium sulfate is administered to stabilize the myocardium and terminate torsades de pointes.

Incorrect. Synchronized cardioversion is used for unstable atrial fibrillation to restore organized electrical activity.

Incorrect. Adenosine is administered as a rapid IV push to terminate SVT in pediatric patients, followed by a saline flush.

Incorrect. Rapid defibrillation within 1 minute of witnessed VF increases the likelihood of survival and ROSC.

Incorrect. The compression fraction should be greater than 80% to maximize perfusion during CPR.

Incorrect. Epinephrine is administered after defibrillation to enhance coronary and cerebral perfusion during resuscitation.

Incorrect. Atropine is given at 0.5 mg IV every 3-5 minutes for unstable bradycardia caused by vagal stimulation or primary AV block.

Incorrect. With an advanced airway in place, compressions continue uninterrupted while breaths are delivered at 6-8 breaths per minute.

Incorrect. Atropine doses should not exceed 3 mg during bradycardia management to avoid adverse effects.

Incorrect. Amiodarone is administered as a 300 mg IV/IO bolus for refractory VF or pulseless VT.

Incorrect. Pulseless VT is treated with defibrillation, while synchronized cardioversion is reserved for tachyarrhythmias with a pulse.

Incorrect. Ventilation with an advanced airway should be provided at a rate of 1 breath every 6 seconds, or 10 breaths per minute.

Incorrect. Biphasic defibrillation begins at 120-200 J to terminate shockable rhythms like VF and pulseless VT effectively.

Incorrect. Naloxone is only used in cases of suspected opioid overdose and is not universally administered in cardiac arrest.

Incorrect. Interruptions in chest compressions should not exceed 10 seconds to maintain adequate perfusion to vital organs.

Incorrect. Amiodarone is the preferred antiarrhythmic for stabilizing wide-complex tachycardia in stable patients.

Incorrect. Hypovolemia is a reversible cause of cardiac arrest and should be corrected with fluid resuscitation.